{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T02:26:31Z","timestamp":1777083991768,"version":"3.51.4"},"reference-count":48,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T00:00:00Z","timestamp":1617408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T00:00:00Z","timestamp":1617408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100012190","name":"\u0424\u0435\u0434\u0435\u0440\u0430\u043b\u044c\u043d\u0430\u044f \u0446\u0435\u043b\u0435\u0432\u0430\u044f \u043f\u0440\u043e\u0433\u0440\u0430\u043c\u043c\u0430","doi-asserted-by":"publisher","award":["12411.1008799.13.120"],"award-info":[{"award-number":["12411.1008799.13.120"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012190","name":"\u0424\u0435\u0434\u0435\u0440\u0430\u043b\u044c\u043d\u0430\u044f \u0446\u0435\u043b\u0435\u0432\u0430\u044f \u043f\u0440\u043e\u0433\u0440\u0430\u043c\u043c\u0430","doi-asserted-by":"publisher","award":["14.N08.12.0010"],"award-info":[{"award-number":["14.N08.12.0010"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00005-021-00613-w","type":"journal-article","created":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T10:02:23Z","timestamp":1617444143000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["New Approaches to the Prevention and Treatment of Viral Diseases"],"prefix":"10.2478","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5266-9783","authenticated-orcid":false,"given":"Alexander V.","family":"Pronin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander N.","family":"Narovlyansky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander V.","family":"Sanin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2021,4,3]]},"reference":[{"key":"613_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.32416\/article_5d935e17e234b1.31437966","volume":"5","author":"VV Annikov","year":"2019","unstructured":"Annikov VV, Narovyansky AN, Sanin AV et al (2019) Correction of dyslipidemia with combined use of beta-sitosterol and polyprenyl phosphates in dogs with type 1 diabetes mellitus. Russian Veterinary J 5:12\u201315. https:\/\/doi.org\/10.32416\/article_5d935e17e234b1.31437966","journal-title":"Russian Veterinary J"},{"key":"613_CR2","doi-asserted-by":"publisher","first-page":"e1000598","DOI":"10.1371\/journal.pbio.1000598","volume":"9","author":"M Blanc","year":"2011","unstructured":"Blanc M, Hsieh WY, Robertson KA (2011) Host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis. PLoS Biol 9:e1000598. https:\/\/doi.org\/10.1371\/journal.pbio.1000598","journal-title":"PLoS Biol"},{"key":"613_CR3","doi-asserted-by":"publisher","first-page":"e0204773","DOI":"10.1371\/journal.pone.0204773","volume":"13","author":"P Bogovi\u010d","year":"2018","unstructured":"Bogovi\u010d P, Lusa L, Stupica D et al (2018) Impact of pre-existing treatment with statins on the course and outcome of tick-borne encephalitis. PLoS ONE 13:e0204773. https:\/\/doi.org\/10.1371\/journal.pone.0204773","journal-title":"PLoS ONE"},{"key":"613_CR4","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1165\/rcmb.2006-0269TR","volume":"36","author":"C Bonnans","year":"2007","unstructured":"Bonnans C, Levy BD (2007) Lipid mediators as agonists for the resolution of acute lung inflammation and injury. Am J Respir Cell Mol Biol 36:201\u2013205. https:\/\/doi.org\/10.1165\/rcmb.2006-0269TR","journal-title":"Am J Respir Cell Mol Biol"},{"key":"613_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.20340\/mv-mn.2015.0(2):15-20","volume":"2","author":"TG Borovaya","year":"2015","unstructured":"Borovaya TG, Didenko LV, Narovlyansky AN et al (2015) Histological characteristics of rete ovarii in acute period of genital herpes virus infection. Morphol Newsl 2:15\u201320. https:\/\/doi.org\/10.20340\/mv-mn.2015.0(2):15-20","journal-title":"Morphol Newsl"},{"key":"613_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.antiviral.2018.05.005","volume":"155","author":"S Chaudhuri","year":"2018","unstructured":"Chaudhuri S, Symons JA, Deval J (2018) Innovation and trends in the development and approval of antiviral medicines: 1987\u20132017 and beyond. Antiviral Res 155:76\u201388. https:\/\/doi.org\/10.1016\/j.antiviral.2018.05.005","journal-title":"Antiviral Res"},{"key":"613_CR7","first-page":"395","volume":"44","author":"LL Danilov","year":"1996","unstructured":"Danilov LL, Maltsev SD, Deyeva AV et al (1996) Phosprenyl: a novel drug with antiviral and immune modulating activity. Arch Immunol Ther Exp 44:395\u2013400","journal-title":"Arch Immunol Ther Exp"},{"key":"613_CR8","unstructured":"Danilov LL, Deeva AV, Maltsev SD et al (2002) Remedy for the prevention and treatment of infectious diseases and the correction of pathological conditions of a living organism. RF Patent No. 2177788, 01\/10\/2002"},{"key":"613_CR9","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1093\/jac\/dkg490","volume":"52","author":"S Einav","year":"2003","unstructured":"Einav S, Glenn JS (2003) Prenylation inhibitors: a novel class of antiviral agents. J Antimicrob Chemother 52:883\u2013886. https:\/\/doi.org\/10.1093\/jac\/dkg490","journal-title":"J Antimicrob Chemother"},{"key":"613_CR10","first-page":"5","volume":"60","author":"FI Ershov","year":"2015","unstructured":"Ershov FI, Narovlyansky AN (2015) Usage of interferon inducers during viral infections. Vopr Virusol 60:5\u201310","journal-title":"Vopr Virusol"},{"key":"613_CR11","unstructured":"Ershov FI, Narovlyansky AN, Pronin AV et al (2017) Genital Herpes in Russia: the Scope of the Problem and Treatment Prospects. In Berhardt LV (ed) Advances in Medicine and Biology, Nova Science Publishers, Inc., New York, vol 124, chapter 6, pp 121\u2013174"},{"key":"613_CR12","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1128\/AAC.45.4.1231-1237.2001","volume":"45","author":"TL Gower","year":"2001","unstructured":"Gower TL, Graham BS (2001) Antiviral activity of lovastatin against respiratory syncytial virus in vivo and in vitro. Antimicrob Agents Chemother 45:1231\u20131237. https:\/\/doi.org\/10.1128\/AAC.45.4.1231-1237.2001","journal-title":"Antimicrob Agents Chemother"},{"key":"613_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.abb.2011.10.018","volume":"517","author":"MD Hartley","year":"2012","unstructured":"Hartley MD, Imperiali B (2012) At the membrane frontier: a prospectus on the remarkable evolutionary conservation of polyprenols and polyprenyl-phosphates. Arch Biochem Biophys 517:83\u201397. https:\/\/doi.org\/10.1016\/j.abb.2011.10.018","journal-title":"Arch Biochem Biophys"},{"key":"613_CR14","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.antiviral.2018.04.016","volume":"154","author":"A Ianevski","year":"2018","unstructured":"Ianevski A, Zusinaite E, Kuivanen S et al (2018) Novel activities of safe-in-human broad-spectrum antiviral agents. Antiviral Res 154:174\u2013182. https:\/\/doi.org\/10.1016\/j.antiviral.2018.04.016","journal-title":"Antiviral Res"},{"key":"613_CR15","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.bbagen.2009.03.030","volume":"1790","author":"MB Jones","year":"2009","unstructured":"Jones MB, Rosenberg JN, Betenbaugh MJ et al (2009) Structure and synthesis of polyisoprenoids used in N-glycosylation across the three domains of life. Biochim Biophys Acta 1790:485\u2013494. https:\/\/doi.org\/10.1016\/j.bbagen.2009.03.030","journal-title":"Biochim Biophys Acta"},{"key":"613_CR16","doi-asserted-by":"publisher","first-page":"8120","DOI":"10.3748\/wjg.v23.i46.8120","volume":"23","author":"T Kanda","year":"2017","unstructured":"Kanda T, Nirei K, Matsumoto N et al (2017) Retreatment of patients with treatment failure of direct-acting antivirals: focus on hepatitis C virus genotype 1b. World J Gastroenterol 23:8120\u20138127. https:\/\/doi.org\/10.3748\/wjg.v23.i46.8120","journal-title":"World J Gastroenterol"},{"key":"613_CR17","unstructured":"Kuritz T (2009) Methods and compositions for modulation of innate immunity, US Patent 0306017"},{"key":"613_CR18","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.jfms.2008.12.002","volume":"11","author":"AM Legendre","year":"2009","unstructured":"Legendre AM, Bartges JW (2009) Effect of Polyprenyl immunostimulant on the survival times of three cats with the dry form of feline infectious peritonitis. J Feline Med Surg 11:624\u2013626. https:\/\/doi.org\/10.1016\/j.jfms.2008.12.002","journal-title":"J Feline Med Surg"},{"key":"613_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fvets.2017.00007","volume":"4","author":"AM Legendre","year":"2017","unstructured":"Legendre AM, Kuritz T, Galyon G et al (2017a) Polyprenyl immunostimulant treatment of cats with presumptive non-effusive feline infectious peritonitis in a field study. Front Vet Sci 4:7. https:\/\/doi.org\/10.3389\/fvets.2017.00007","journal-title":"Front Vet Sci"},{"key":"613_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fvets.2017.00024","volume":"4","author":"AM Legendre","year":"2017","unstructured":"Legendre AM, Kuritz T, Heidel RE et al (2017b) Polyprenyl immunostimulant in feline rhinotracheitis: randomized placebo-controlled experimental and field safety studies. Front Vet Sci 4:24. https:\/\/doi.org\/10.3389\/fvets.2017.00024","journal-title":"Front Vet Sci"},{"issue":"10","key":"613_CR21","doi-asserted-by":"publisher","first-page":"1700014","DOI":"10.1002\/bies.201700014","volume":"39","author":"ES Marakasova","year":"2017","unstructured":"Marakasova ES, Eisenhaber B, Maurer-Stroh S et al (2017) Prenylation of viral proteins by enzymes of the host: virus-driven rationale for therapy with statins and FT\/GGT1 inhibitors. BioEssays 39(10):1700014. https:\/\/doi.org\/10.1002\/bies.201700014","journal-title":"BioEssays"},{"key":"613_CR22","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000321892","volume":"54","author":"M Mart\u00ednez-Gutierrez","year":"2011","unstructured":"Mart\u00ednez-Gutierrez M, Castellanos JE, Gallego-G\u00f3mez JC (2011) Statins reduce dengue virus production via decreased virion assembly. Intervirology 54:202\u2013216. https:\/\/doi.org\/10.1159\/000321892","journal-title":"Intervirology"},{"key":"613_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1600-065X.2006.00479.x","volume":"215","author":"CT Morita","year":"2007","unstructured":"Morita CT, Jin C, Sarikonda G et al (2007) Nonpeptide antigens, presentation mechanisms, and immunological memory of human V\u03b32V\u03b42 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens. Immunol Rev 215:59\u201376. https:\/\/doi.org\/10.1111\/j.1600-065X.2006.00479.x","journal-title":"Immunol Rev"},{"key":"613_CR24","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.coph.2016.08.003","volume":"30","author":"L Naesens","year":"2016","unstructured":"Naesens L, Stevaert A, Vanderlinden E (2016) Antiviral therapies on the horizon for influenza. Curr Opin Pharmacol 30:106\u2013115. https:\/\/doi.org\/10.1016\/j.coph.2016.08.003","journal-title":"Curr Opin Pharmacol"},{"key":"613_CR25","first-page":"81","volume":"5","author":"AN Narovlyansky","year":"2012","unstructured":"Narovlyansky AN, Deriabin PG, Sedov AM et al (2012) Antiviral activity of polyprenyl phosphates in an experimental infection caused by the hepatitis C virus in vitro. Zh J Microbiol Epidemiol Immunobiol 5:81\u201384 ((Article in Russian))","journal-title":"Zh J Microbiol Epidemiol Immunobiol"},{"key":"613_CR26","first-page":"54","volume":"5","author":"AN Narovlyansky","year":"2014","unstructured":"Narovlyansky AN, Ozherelkov SV, Sanin AV et al (2014) Antiviral activity and possible mechanisms of action of moraprenyl phosphates in experimental infection caused by the herpes simplex virus type 1. Zh J Microbiol Epidemiol Immunobiol 5:54\u201360 ((Article in Russian))","journal-title":"Zh J Microbiol Epidemiol Immunobiol"},{"key":"613_CR27","first-page":"112","volume":"4","author":"AN Narovlyansky","year":"2015","unstructured":"Narovlyansky AN, Sedov AM, Pronin AV et al (2015b) Treatment of patients with chronic recurrent herpesvirus infection of genital localization: a clinical study of Fortepren preparation. Zh J Microbiol Epidemiol Immunobiol 4:112\u2013118","journal-title":"Zh J Microbiol Epidemiol Immunobiol"},{"key":"613_CR28","first-page":"9","volume":"60","author":"AN Narovlyansky","year":"2015","unstructured":"Narovlyansky AN, Ivanova AM, Shevlyagina NV et al (2015d) Efficiency of polyprenyl phosphates in experimental model of genital herpes. Vopr Virusol 60:9\u201313","journal-title":"Vopr Virusol"},{"key":"613_CR29","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.cyto.2015.08.112","volume":"76","author":"AN Narovlyansky","year":"2015","unstructured":"Narovlyansky AN, Pronin AV, Sanin AV et al (2015c) ID: 85: the cytokine-regulating activity of polyprenyl phosphates: clinical studies of ForteprenR. Cytokine 76:80\u201381. https:\/\/doi.org\/10.1016\/j.cyto.2015.08.112","journal-title":"Cytokine"},{"key":"613_CR30","first-page":"9","volume":"60","author":"AN Narovlyansky","year":"2015","unstructured":"Narovlyansky AN, Ivanova AM, Shevlyagina NV et al (2015a) Effectiveness of the use of polyprenyl phosphates in the experimental model of genital herpes. Vopr Virusol 60:9\u201313","journal-title":"Vopr Virusol"},{"key":"613_CR31","first-page":"183","volume-title":"Isoprenoids: polyprenols and plyprenyl phosphates as physiologically important metabolic regulators","author":"AN Narovlyansky","year":"2018","unstructured":"Narovlyansky AN, Pronin AV, Sanin AV et al (2018) Isoprenoids: polyprenols and plyprenyl phosphates as physiologically important metabolic regulators. Nova Science Publishers Inc, New York, p 183"},{"key":"613_CR32","first-page":"33","volume":"45","author":"SV Ozherelkov","year":"2000","unstructured":"Ozherelkov SV, Timofeev AV, Novikova GP et al (2000) Protective effect of the new antiviral drug Phosprenyl with experimental tick-borne encephalitis. Vopr Virusol 45:33\u201337","journal-title":"Vopr Virusol"},{"key":"613_CR33","first-page":"43","volume":"5","author":"SV Ozherelkov","year":"2001","unstructured":"Ozherelkov SV, Belousova RV, Danilov LL et al (2001) Phosprenyl inhibits the proliferation of cattle diarrhea virus and bovine infectious rhinotracheitis virus in sensitive cell cultures. Vopr Vir 5:43\u201345 ((PMID: 11715710))","journal-title":"Vopr Vir"},{"key":"613_CR34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1021\/cb500791f","volume":"10","author":"CC Palsuledesai","year":"2015","unstructured":"Palsuledesai CC, Distefano MD (2015) Protein prenylation: enzymes, therapeutics, and biotechnology applications. ACS Chem Biol 10:51\u201362. https:\/\/doi.org\/10.1021\/cb500791f","journal-title":"ACS Chem Biol"},{"key":"613_CR35","first-page":"156","volume":"5","author":"AV Pronin","year":"2000","unstructured":"Pronin AV, Ozerelkov SV, Narovlyansky AN et al (2000) Role of cytokines in immunomodulatory effects of polyprenylphosphate: new generation of antiviral drug. Russ J Immunol 5:156\u2013164","journal-title":"Russ J Immunol"},{"key":"613_CR36","first-page":"135","volume":"7","author":"AV Pronin","year":"2002","unstructured":"Pronin AV, Grigorieva EA, Sanin AV et al (2002) Polyprenols as possible factors that determine an instructive role of the innate immunity in the acquired immune response. Russ J Immunol 7:135\u2013142","journal-title":"Russ J Immunol"},{"key":"613_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00005-013-0253-y","volume":"62","author":"AV Pronin","year":"2014","unstructured":"Pronin AV, Danilov LL, Narovlyansky AN et al (2014a) Plant polyisoprenoids and control of cholesterol level. Arch Immunol Ther Exp 62:31\u201339. https:\/\/doi.org\/10.1007\/s00005-013-0253-y","journal-title":"Arch Immunol Ther Exp"},{"key":"613_CR38","doi-asserted-by":"publisher","first-page":"645","DOI":"10.15789\/2220-7619-2012-3-645-650","volume":"2","author":"AV Pronin","year":"2014","unstructured":"Pronin AV, Ozherelkov SV, Deeva AV et al (2014b) Polyprenyl phosphates as adjuvants polarizing the immune response towards Th1. Russian J Infect Immun 2:645. https:\/\/doi.org\/10.15789\/2220-7619-2012-3-645-650","journal-title":"Russian J Infect Immun"},{"key":"613_CR39","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.cytogfr.2016.04.001","volume":"30","author":"AV Pronin","year":"2016","unstructured":"Pronin AV, Narovlyansky AN, Shulzhenko AE et al (2016) New polyprenyl phosphate based preparation Fortepren as promising cytokine regulating antiviral remedy. Cytokine Growth Factor Rev 30:119\u2013126. https:\/\/doi.org\/10.1016\/j.cytogfr.2016.04.001","journal-title":"Cytokine Growth Factor Rev"},{"key":"613_CR40","first-page":"355","volume":"4","author":"AV Sanin","year":"2011","unstructured":"Sanin AV, Ganshina IV, Sudyina GF et al (2011a) Phosphorylated polyprenols are a new class of compounds with anti-inflammatory and bronchodilator activity. Russian J Infect Immun 4:355\u2013360","journal-title":"Russian J Infect Immun"},{"key":"613_CR41","unstructured":"Sanin AV, Narovlyansky AN, Pronin AV (2011b) Immunomodulators in agriculture: a tribute to fashion or necessity? Russian Veterinary J 1:37\u201340. https:\/\/cyberleninka.ru\/article\/n\/immunomodulyatory-v-selskom-hozyaystve-dan-mode-ili-neobhodimost\/viewer"},{"key":"613_CR42","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.abb.2010.06.004","volume":"501","author":"R Sato","year":"2010","unstructured":"Sato R (2010) Sterol metabolism and SREBP activation. Arch Biochem Biophys 501:177\u2013181. https:\/\/doi.org\/10.1016\/j.abb.2010.06.004","journal-title":"Arch Biochem Biophys"},{"key":"613_CR43","doi-asserted-by":"publisher","first-page":"81","DOI":"10.36233\/0372-9311-2018-5-81-87","volume":"5","author":"AM Sedov","year":"2018","unstructured":"Sedov AM, Narovlyansky AN, Pronin AV et al (2018) Mechanism of antiviral action and evaluation of the effectiveness of the new drug Fortepren\u00ae in the treatment of chronic recurrent herpes virus infection of genital localization. J Microbiol Epidemiol Immunobiol 5:81\u201387. https:\/\/doi.org\/10.36233\/0372-9311-2018-5-81-87","journal-title":"J Microbiol Epidemiol Immunobiol"},{"key":"613_CR44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.15789\/1563-0625-2010-1-2-13-20","volume":"12","author":"SM Sobolev","year":"2010","unstructured":"Sobolev SM, NikolaevaTN GEA et al (2010) The role of lectin-substrate recognition in the immunoregulatory interaction of interleukin-2 and IgG. Med Immunol 12:13\u201320. https:\/\/doi.org\/10.15789\/1563-0625-2010-1-2-13-20","journal-title":"Med Immunol"},{"key":"613_CR45","first-page":"3","volume":"53","author":"ANSVVV Vasil\u2019evOzherelkovKozlov","year":"2008","unstructured":"Vasil\u2019evOzherelkovKozlov ANSVVV et al (2008) Antiviral and immunomodulating activity of polyprenyl phosphates in viral infections. Antibiot Khimioter 53:3\u20138","journal-title":"Antibiot Khimioter"},{"key":"613_CR46","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10719-012-9417-y","volume":"30","author":"M Welti","year":"2013","unstructured":"Welti M (2013) Regulation of dolichol-linked glycosylation. Glycoconj J 30:51\u201356. https:\/\/doi.org\/10.1007\/s10719-012-9417-y","journal-title":"Glycoconj J"},{"key":"613_CR47","unstructured":"WHO (2007\u20132017) Viral hepatitis: a secret killer becomes apparent. https:\/\/www.who.int\/publications\/10-year-review\/hepatitis\/en\/"},{"key":"613_CR48","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.fitote.2015.09.008","volume":"106","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Huang L, Zhang C et al (2015) Synthesis and biological activity of polyprenols. Fitotherapia 106:184\u2013193. https:\/\/doi.org\/10.1016\/j.fitote.2015.09.008","journal-title":"Fitotherapia"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-021-00613-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00005-021-00613-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-021-00613-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T20:49:31Z","timestamp":1704228571000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00005-021-00613-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,3]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["613"],"URL":"https:\/\/doi.org\/10.1007\/s00005-021-00613-w","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"value":"0004-069X","type":"print"},{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,3]]},"assertion":[{"value":"30 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"10"}}